Loading clinical trials...
Loading clinical trials...
Plantar Fasiit Tedavisinde ESWT ve Tüm Vücut Vibrasyon Uygulamalarının Etkinliğinin Karşılaştırılması: Randomize, Prospektif, Tek Kör Çalışma
Plantar fasciitis is a common cause of heel pain that can lead to functional limitation and decreased quality of life. Various conservative treatment modalities are used in its management. This study aims to compare the effectiveness of extracorporeal shock wave therapy (ESWT) and whole body vibration therapy in patients with plantar fasciitis. The study is designed as a randomized, prospective, single-blind clinical trial. Clinical outcomes will be evaluated using pain and functional assessment scales before and after treatment.
This randomized, prospective, single-blind clinical trial was conducted to compare the effects of extracorporeal shock wave therapy (ESWT) and whole body vibration therapy in patients diagnosed with plantar fasciitis. A total of 60 patients aged between 18 and 65 years were included in the final analysis. Participants were randomly assigned into two groups. The first group received extracorporeal shock wave therapy applied once weekly for a total of five sessions. The second group received whole body vibration therapy three times per week for five weeks. Both groups followed the same standardized home exercise program during the treatment period. Clinical evaluations were performed at baseline, at the end of treatment, and at the ninth week. The primary outcome measure was functional status assessed using the Foot Function Index (FFI). Secondary outcome measures included pain intensity assessed by the Visual Analog Scale (VAS), the American Orthopaedic Foot and Ankle Society (AOFAS) score, and the Roles and Maudsley score.The aim of this study is to determine and compare the clinical effectiveness of ESWT and whole body vibration therapy in the management of plantar fasciitis.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Gaziosmanpaşa Training and Research Hospital
Istanbul, Turkey (Türkiye)
Start Date
August 1, 2025
Primary Completion Date
March 20, 2026
Completion Date
March 20, 2026
Last Updated
March 11, 2026
60
ACTUAL participants
Extracorporeal Shock Wave Therapy
DEVICE
Whole Body Vibration Therapy
DEVICE
Lead Sponsor
Gaziosmanpasa Research and Education Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06284993